Skip to content

Discontinued — last reported Q4 '22

Gross margin at other companies

Scilex Holding Company logo
Scilex Holding CompanySCLX
59.7%-12.3pp
StoneX Group Inc. logo
StoneX Group Inc.SNEX
-5,500.2%-539pp
TEC
Bio-TechneTECH
65%-0.8pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
51.9%-1.6pp

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Calculated from BioSig Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The official record: BioSig Technologies, Inc.’s 10-K, filed April 15, 2025, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s gross margin?
BioSig Technologies, Inc. (STEX) reported gross margin of 80.1% in Q4 2022.
How has BioSig Technologies, Inc.'s gross margin changed year-over-year?
BioSig Technologies, Inc.'s gross margin increased by 45.9% year-over-year, from 54.9% to 80.1%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.